Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function

British Journal of Anaesthesia

Volumn 81, Issue 4, 1998, Pages 569-577

  Nietgen, Gregor W ^a   Hönemann, Christian W ^a   Chan, Carrie K ^a   Kamatchi, Ganesan L ^a   Durieux, Marcel E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anaesthetics volatile; Receptors, muscarinic; Theories of anaesthetic action, molecular

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CALCIUM ION; DESFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; INOSITOL TRISPHOSPHATE; ISOFLURANE; METHACHOLINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; RECOMBINANT RECEPTOR; SEVOFLURANE;

ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; COGNITION; CONCENTRATION RESPONSE; CONSCIOUSNESS; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; NOCICEPTION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; XENOPUS;

EID: 0031666857     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/81.4.569     Document Type: Article

References (41)

1. Lodge D, Anis NA, Burton NR. Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine. Neuroscience Letters 1982; 29: 281-286.
2. Zaagsma J, Roffel AF, Meurs H. Muscarinic control of airway function. Life Sciences 1997; 60: 1061-1068.
3. Durieux ME. Muscarinic signalling in the central nervous system: Recent developments and anesthetic implications. Anesthesiology 1996; 84: 173-189.
4. Lucidi-Phillipi CA, Gage FH. The neurotrophic hypothesis and the cholinergic basal forebrain projection. Progress in Brain Research 1993; 98: 241-249.
5. Price DL, Koliatsos VE, Clatterbuck RC. Cholinergic systems: human diseases, animal models, and prospects for therapy. Progress in Brain Research 1993; 98: 51-60.
6. Gillberg P-G, Aquinolius S-M. Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography; changes in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 1985; 72: 299-306.
7. Scatton B, Dubois A, Javoy-Agid F, Camus A. Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord. Neuroscience Letters 1984; 49: 239-245.
8. Yamamoto K, Morimoto N, Warner DO, Rehder K, Jones KA. Factors influencing the direct actions of volatile anesthetics on airway smooth muscle. Anesthesiology 1993; 78: 1102-1111.
9. Anthony BL, Dennison RL, Aronstam RS. Influence of volatile anesthetics on muscarinic regulation of adenylate cyclase activity. Biochemical Pharmacology 1990; 40: 376-379.
10. Anthony BL, Dennison RL, Narayanan TK, Aronstam RS. Diethyl ether effects on muscarinic acetylcholine receptor complexes in rat brainstem. Biochemical Pharmacology 1988; 37: 4041-4046.
11. Dennison RL, Anthony BL, Narayanan TK, Aronstam RS. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology 1987; 26: 1201-1205.
12. Anthony BL, Dennison RL, Aronstam RS. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neuroscience Letters 1989; 99: 191-196.
13. Durieux ME. Halothane inhibits signalling through m1 muscarinic receptors expressed in Xenopus oocytes. Anesthesiology 1995; 82: 174-182.
14. Durieux ME. Inhibition by ketamine of muscarinic acetyl-choline receptor function. Anesthesia and Analgesia 1995; 81: 57-62.
15. Levey AI. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sciences 1993; 52:441-448.
16. Vilaro MT, Mengod G, Palacios JM. Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors. Progress in Brain Research 1993; 98: 95-101.
17. Ebert TJ, Muzi M. Sympathetic activation with desflurane in humans. Advances in Pharmacology 1994; 31: 369-378.
18. Muzi M, Lopatka CW, Ebert TJ. Desflurane-mediated neurocirculatory activation in humans. Effects of concentration and rate of change on responses. Anesthesiology 1996; 84: 1035-1042.
19. Weiskopf RB, Eger EI, Daniel M, Noorani M. Cardiovascular stimulation induced by rapid increases in desflurane concentration in humans results from activation of tracheopulmonary and systemic receptors. Anesthesiology 1995; 83: 1173-1178.
20. Tigyi G, Dyer DL, Matute C, Miledi R. A serum factor that activates the phosphotidylinositol phosphate signalling system in Xenopus oocytes. Proceedings of the National Academy of Sciences USA 1990; 87: 1521-1525.
21. - current in Xenopus oocytes is mediated through a β-type phospholipase C; cloning a new form of the enzyme. Journal of Biological Chemistry 1993; 268: 19915-19918.
22. Ferguson JE, Hanley MR. Phosphatidic acid and lysophosphatidic acid stimulate receptor-regulated membrane currents in the Xenopus laevis oocyte. Archives of Biochemistry and Biophysics 1992; 297: 388-392.
23. Durieux ME, Lynch KR. Signalling properties of lysophosphatidic acid. Trends in Pharmacological Sciences 1993; 14: 249-254.
24. Durieux ME. OoClamp: An IBM-compatible software system for the study of receptors expressed in Xenopus oocytes. Computer Methods and Programs in Biomedicine 1993; 41: 101-105.
25. - current in Xenopus laevis oocytes. American Journal of Physiology 1992; 263: C896-900.
26. Renzi F, Waud BE. Partition coefficients of volatile anesthetics in Kreb's solution. Anesthesiology 1977; 47: 62-63.
27. Miao N, Lynch C. Effect of temperature on volatile anesthetic depression of myocardial contractions. Anesthesia and Analgesia 1993; 76: 366-371.
28. Smith RA, Porter EG, Miller KW. The solubility of anesthetic gases in lipid bilayers. Biochimica et Biophysica Acta 1981; 645: 327-338.
29. Chan CK, Durieux ME. Effects of halothane and isoflurane on lysophosphatidate signalling. Anesthesiology 1997; 86: 660-669.
30. 2 signalling. Anesthesiology 1998; 88: 440-451.
31. Ayabe T, Kopf GS, Schultz RM. Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs. Development 1995; 121: 2233-2244.
32. Knecht M, Darbon JM, Ranta T, Baukai A, Gatt KJ. Inhibitory actions of adenosine on follicle-stimulating hormone- induced differentiation of cultured rat granulosa cells. Biological Reproduction 1984; 30: 1082-1090.
33. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (London) 1986; 323:411-416.
34. Lin LH, Leonard S, Harris A. Enflurane inhibits the function of mouse and human brain phosphatidylinositol-linked acetylcholine and serotonin receptors expressed in Xenopus oocytes. Molecular Pharmacology 1993; 43: 941-948.
35. Young WL. Effects of desflurane on the central nervous system. Anesthesia and Analgesia 1992; 75: S32-37.
36. Jones RM, Cashman JN, Mant TG. Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (I-653), in volunteers. British Journal of Anaesthesia 1990; 64: 11-15.
37. Warltier DC, Pagel PS. Cardiovascular and respiratory actions of desflurane: is desflurane different from isoflurane? Anesthesia and Analgesia 1992; 75 (Suppl): S17-29.
38. Weiskopf RB, Eger EI, Noorani M, Daniel M. Repetitive rapid increases in desflurane concentration blunt transient cardiovascular stimulation in humans. Anesthesiology 1994; 81: 843-849.
39. Pagel PS, Kampine JP, Schmeling WT, Warltier DC. Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog. Anesthesiology 1991; 74: 539-551.
40. Patel SS, Goa KL. Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia. Drugs 1995; 50: 742-767.
41. Simon RP, Griffiths T, Evans MC, Swan JH, Meldrum BS. Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia; an electron microscopy study in the rat. Journal of Cerebral Blood Flow and Metabolism 1984; 4: 350-361.